A systematic review exploring challenges of informed consent processes in antipsychotic prescribing

References

• Bowler, N., Moss, S., Winston, M., & Coleman, M. (2000). An audit of psychiatric case notes in relation to antipsychotic medication and information giving the psychoses. British Journal of Clinical Governance, 5(4), 212–216. https://doi.org/10.1108/14664100010361773
   Google Scholar
• Brabbins, C., Butler, J., & Bentall, R. (1996). Consent to neuroleptic medication for schizophrenia: Clinical ethical and legal issues. British Journal of Psychiatry, 168(5), 540–544. https://doi.org/10.1192/bjp.168.5.540
   PubMed Web of Science ®Google Scholar
• Brunton, G., Oliver, S., & Thomas, J. (2020). Innovations in framework synthesis as a systematic review method. Research Synthesis Methods, 11(3), 316–330. https://doi.org/10.1002/jrsm.1399
   PubMed Web of Science ®Google Scholar
• Buckley, N. A., & Sanders, P. (2000). Cardiovascular adverse effects of antipsychotic drugs. Drug Safety, 23(3), 215–228. https://doi.org/10.2165/00002018-200023030-00004
   PubMed Web of Science ®Google Scholar
• Cancro, R., Davis, J. M., Klawans, H., & Tancredi, L. (1981). Medical and legal implications of side effects from neuroleptic drugs. A round table discussion. The Journal ofClinical Psychiatry, 42(2), 78–82.
   PubMed Web of Science ®Google Scholar
• Cave, E. (2017). Protecting patients from their bad decisions: Rebalancing rights, relationships, and risk. Medical Law Review, 25(4), 527–553. https://doi.org/10.1093/medlaw/fww046
   PubMed Web of Science ®Google Scholar
• Chaplin, R., Lelliott, P., Quirk, A., & Seale, C. (2007). Negotiating styles adopted by consultant psychiatrists when prescribing antipsychotics. Advances in Psychiatric Treatment, 13(1), 43–50. https://doi.org/10.1192/apt.bp.106.002709
   Google Scholar
• Chaplin, R., & Timehin, C. (2002). Informing patients about tardive dyskinesia: Four-year follow up of a trial of patient education. Australian and New Zealand Journal of Psychiatry, 36(1), 99–103. https://doi.org/10.1046/j.1440-1614.2002.00979.x
   PubMed Web of Science ®Google Scholar
• Davis, J.M., & Comaty, J. (1988). Legal aspects of tardive dyskinesia. L’Encephale, 14, 257–261.
   PubMedGoogle Scholar
• Eastwood, N., & Pugh, R. (1997). Long-term medication in depot clinics and patients’ rights: An issue for assertive outreach. Psychiatric Bulletin, 21, 273–276. https://doi.org/10.1192/pb.21.5.273
   Google Scholar
• Freishtat, H. W., & Einhorn, A. H. (1981). Heads or tails you lose: The dilemmas of psychiatric informed. Journal of Clinical Psychopharmacology, 1(2), 98–101. https://doi.org/10.1097/00004714-198103000-00012
   PubMedGoogle Scholar
• Gefenas, E. (2012). Informed consent. In R. Chadwick, D. Callahan & P. Singer (Eds.), Encyclopedia of applied ethics (2nd ed., pp. 721–730).
   Google Scholar
• Goldbeck, R., Tomlinson, S., & Bouch, J. (1999). Patients’ knowledge and views of their depot neuroleptic medication. Psychiatric Bulletin, 23, 467–470. https://doi.org/10.1192/pb.23.8.467
   Google Scholar
• Goldfarb, E., Fromson, J. A., Gorrindo, T., & Birnbaum, R. J. (2012). Enhancing informed consent best practices: Gaining patient, family and provider perspectives using reverse simulation. Journal of Medical Ethics, 38(9), 546–551. https://doi.org/10.1136/medethics-2011-100206
   PubMed Web of Science ®Google Scholar
• Harris, N., Lovell, K., & Day, J. (2002). Consent and long-term neuroleptic treatment. Journal of Psychiatric & Mental Health Nursing, 9(4), 475–482. https://doi.org/10.1046/j.1365-2850.2002.00463.x
   PubMedGoogle Scholar
• Higgins, A., Barker, P.,& Begley, C.M. (2006). Iatrogenic sexual dysfunction and withholding of information Iatrogenic sexual dysfunction and the protective withholding of information: In whose best interest? Journal of Psychiatric & Mental Health Nursing, 13(4), 437–446. https://doi.org/10.1111/j.1365-2850.2006.01001.x
   PubMed Web of Science ®Google Scholar
• Huggett, C., Birtel, M. D., Awenat, Y. F., Fleming, P., Wilkes, S., Williams, S., & Haddock, G. (2018). A qualitative study: Experiences of stigma by people with mental health problems. Psychology & Psychotherapy: Theory, Research & Practice, 91(3), 380–397. https://doi.org/10.1111/papt.12167
   PubMed Web of Science ®Google Scholar
• Ingelfinger, F. J. (1972). Informed (but uneducated) consent. New England Journal of Medicine, 287(9), 465–466. https://doi.org/10.1056/NEJM197208312870912
   PubMed Web of Science ®Google Scholar
• Katz, S., Goldblatt, H., Hasson-Ohayon, I., & Roe, D. (2019). Retrospective accounts of the process of using and discontinuing psychiatric medication. Qualitative Health Research, 29(2), 198–210. https://doi.org/10.1177/1049732318793418
   PubMed Web of Science ®Google Scholar
• Keepers, G. A., Fochtmann, L. J., Anzia, J. M., Benjamin, S., Lyness, J. M., Mojtabai, R., Servis, M., Walaszek, A., Buckley, P., Lenzenweger, M. F., Young, A. S., Degenhardt, A., & Hong, S. H. (2020). The American psychiatric association practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry, 177(9), 868–872. https://doi.org/10.1176/appi.ajp.2020.177901
   PubMed Web of Science ®Google Scholar
• Kitamura, T. (2005). Stress-reductive effects of information disclosure to medical and psychiatric patients. Psychiatry and Clinical Neurosciences, 59(6), 627–633. https://doi.org/10.1111/j.1440-1819.2005.01428.x
   PubMed Web of Science ®Google Scholar
• Kleinman, I., Schachter, D., Jeffries, J., Goldhamer, P. (1996). Informed consent and tardive dyskinesia: Long-term follow-up. Journal of Nervous & Mental Disease, 184(9), 517–522. https://doi.org/10.1097/00005053-199609000-00001
   PubMed Web of Science ®Google Scholar
• Kleinman, I., Schachter, D., & Koritar, E. (1989). Informed consent and tardive dyskinesia. American Journal of Psychiatry, 146(7), 902–904.
   PubMed Web of Science ®Google Scholar
• Laugharne, J., & Brown, S. (1998). Informed consent and antipsychotic use in patients with schizophrenia issues and recommendations. Current Opinion CNS Drugs, 9(1), 1–5. https://doi.org/10.2165/00023210-199809010-00001
   Web of Science ®Google Scholar
• Laugharne, J., Davies, A., Arcelus, J., & Bouman, W. P. (2004). Informing patients about tardive dyskinesia: A survey of clinicians’ attitudes in three countries. International Journal of Law and Psychiatry, 27(1), 101–108. https://doi.org/10.1016/j.ijlp.2003.12.004
   PubMed Web of Science ®Google Scholar
• Linden, M., & Chaskel, R. (1981). Information and consent in schizophrenic patients in long-term treatment. Schizophrenia Bulletin, 7(3), 372–378. https://doi.org/10.1093/schbul/7.3.372
   PubMed Web of Science ®Google Scholar
• Martínez-Hernáez, Á., Pié-Balaguer, A., Serrano-Miguel, M., Morales-Sáez, N., García-Santesmases, A., Bekele, D., & Alegre-Agís, E. (2020). The collaborative management of antipsychotic medication and its obstacles: A qualitative study. Social Science and Medicine, 247, 247. https://doi.org/10.1016/j.socscimed.2020.112811
   Web of Science ®Google Scholar
• Masand, P. S., Schwartz, T. L., Wang, X., Kuhles, D. J., Gupta, S., Agharkar, B., Manjooran, J., Hameed, M. A., Hardoby, W., Virk, S., & Frank, B. (2002). Prescribing conventional antipsychotics in the era of novel antipsychotics: Informed consent issues. American Journal of Therapeutics, 9(6), 484–487. https://doi.org/10.1097/00045391-200211000-00004
   PubMedGoogle Scholar
• Mcmurray, L. (2002). Applying principles of informed consent to clinical practice in Psychiatry. CPA Bulletin de I’APC, 34, 16–18.
   Google Scholar
• Nha Hong, Q., Gonzalez-Reyes, A., & Pluye, P. (2018). Improving the usefulness of tool for appraising the quality of qualitative, quantitative and mixed methods studies, the Mixed Methods Appraisal Tool (MMAT). Journal of Evaluation in Clinical Practice, 24(3), 459–467. https://doi.org/10.1111/jep.12884
   PubMed Web of Science ®Google Scholar
• NHS. (2022a, September 7). Mental health act. https://www.nhs.uk/mental-health/social-care-and-your-rights/mental-health-and-the-law/mental-health-act/
   Google Scholar
• NHS. (2022b, December 8). Overview: Consent to treatment. https://www.nhs.uk/conditions/consent-to-treatment/#:~:text=Consent%20to%20treatment%20means%20a,an%20explanation%20by%20a%20clinician.
   Google Scholar
• NHS. (2023, September 19). Advance decision to refuse treatment (living will). https://www.nhs.uk/conditions/end-of-life-care/planning-ahead/advance-decision-to-refuse-treatment/
   Google Scholar
• NICE Clinical Guidance [CG178]. (2014). Psychosis and schizophrenia in adults: The guideline on treatment and management. https://www.nice.org.uk/guidance/cg178
   Google Scholar
• Noor, U. S., Muraruaiah, S., & Chandrashekar, H. (2019). Medication adherence in schizophrenia: Understanding patient’s views. National Journal of Physiology, Pharmacy and Pharmacology, 1. https://doi.org/10.5455/njppp.2019.9.0206002032019
   Google Scholar
• Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
   Google Scholar
• Pies, R. (2007). How ‘objective’ are psychiatric diagnoses? Pyschiatry, 10, 18–22.
   Google Scholar
• Pozón, S. R. (2015). Elementos necesarios al consentimiento informado en pacientes con esquizofrenia. Revista Bioética, 23(1), 20–30. https://doi.org/10.1590/1983-80422015231042
   Google Scholar
• Rajkumar, A. P., Horsdal, H. T., Wimberley, T., Cohen, D., Mors, O., Børglum, A. D., & Gasse, C. (2017). Endogenous and antipsychotic-related risks for diabetes mellitus in young people with schizophrenia: A danish population-based cohort study. The American Journal of Psychiatry, 174(7), 686–694. https://doi.org/10.1176/appi.ajp.2016.16040442
   PubMed Web of Science ®Google Scholar
• Read, J. (2022). The experiences of 585 people when they tried to withdraw from antipsychotic drugs. Addictive Behaviors Reports, 15, 100421. https://doi.org/10.1016/j.abrep.2022.100421
   PubMedGoogle Scholar
• Read, J., & Sacia, A. (2020). Using open questions to understand 650 people’s experiences with antipsychotic drugs. Schizophrenia Bulletin, 46(4), 896–904. https://doi.org/10.1093/schbul/sbaa002
   PubMed Web of Science ®Google Scholar
• Read, J., & Williams, J. (2019). Positive and negative effects of antipsychotic medication: An international online survey of 832 recipients. Current Drug Safety, 14(3), 173–181. https://doi.org/10.2174/1574886314666190301152734
   PubMed Web of Science ®Google Scholar
• Roe, D., Goldblatt, H., Baloush-Klienman, V., Swarbrick, M., & Davidson, L. (2009). Why and how people decide to stop taking prescribed psychiatric medication: Exploring the subjective process of choice. Psychiatric Rehabilitation Journal, 33(1), 38–46. https://doi.org/10.2975/33.1.2009.38.46
   PubMed Web of Science ®Google Scholar
• Rofail, D., Heelis, R., & Gournay, K. (2009). Results of a thematic analysis to explore the experiences of patients with schizophrenia taking antipsychotic medication. Clinical Therapeutics, 31(SUPPL. 1), 1488–1496. https://doi.org/10.1016/j.clinthera.2009.07.001
   PubMedGoogle Scholar
• Rössler, W. (2016). The stigma of mental disorders. EMBO Reports, 17(9), 1250–1253. https://doi.org/10.15252/embr.201643041
   PubMed Web of Science ®Google Scholar
• Royal College of Psychiatrists. (2018, August). Being sectioned (in England and Wales). https://www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/being-sectioned
   Google Scholar
• Royal College of Psychiatrists. (2023). Report CR190: The risks and benefits of high-dose antipsychotic medication.
   Google Scholar
• Salomon, C., Hamilton, B., & Elsom, S. (2014). Experiencing antipsychotic discontinuation: Results from a survey of Australian consumers. Journal of Psychiatric and Mental Health Nursing, 21(10), 917–923. https://doi.org/10.1111/jpm.12178
   PubMed Web of Science ®Google Scholar
• Schachter, D. C., & Kleinman, I. (2004). Psychiatrists’ attitudes about and informed consent practices for antipsychotics and tardive dyskinesia. Psychiatric Services, 55(6), 714–717. https://doi.org/10.1176/appi.ps.55.6.714
   PubMed Web of Science ®Google Scholar
• Schachter, D., Kleinman, I., & Williams, F. J. I. (1999). Informed consent for antipsychotic medication do family physicians document obtaining it? Canadian Family Physician Medecin de Famille Canadien, 45, 1502–1508.
   PubMed Web of Science ®Google Scholar
• Takeuchi, H., Suzuki, T., Uchida, H., Watanabe, K., & Mimura, M. (2012). Antipsychotic treatment for schizophrenia in the maintenance phase: A systematic review of the guidelines and algorithms. Schizophrenia Research, 134(2–3), 219–225. https://doi.org/10.1016/j.schres.2011.11.021
   PubMed Web of Science ®Google Scholar
• Thompson, J., Stansfeld, J. L., Cooper, R. E., Morant, N., Crellin, N. E., & Moncrieff, J. (2020). Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: A systematic review and thematic synthesis of qualitative data. Social Psychiatry & Psychiatric Epidemiology, 55(2), 151–164. https://doi.org/10.1007/s00127-019-01819-2
   PubMed Web of Science ®Google Scholar
• Tryer, P. (2000). A patient who changed my practice: The case for patient-based evidence versus trial-based evidence. International Journal of Psychiatry in Clinical Practice, 4(3), 253–255. https://doi.org/10.1080/13651500050518181
   PubMed Web of Science ®Google Scholar
• Tryer, P., Smith, J., & Adshead, G. (1994). Ethical dilemmas in drug treatments. Psychiatric Bulletin, 18(4), 203–204. https://doi.org/10.1192/pb.18.4.203
   Google Scholar
• Usher Rn, K. J., Dhs, R., Frcna, F., & Arthur, D. (1998). Process consent: A model for enhancing informed consent in mental health nursing. Journal of Advanced Nursing, 27(4), 692–697. https://doi.org/10.1046/j.1365-2648.1998.00589.x
   PubMed Web of Science ®Google Scholar
• Ventura, C. A. A., Austin, W., Carrara, B. S., & de Brito, E. S. (2021). Nursing care in mental health: Human rights and ethical issues. Nursing Ethics, 28(4), 463–480. https://doi.org/10.1177/0969733020952102
   PubMed Web of Science ®Google Scholar
• Waterreus, A., Morgan, V. A., Castle, D., Galletly, C., Jablensky, A., DiPrinzio, P., & Shah, S. (2012). Medication for psychosis – Consumption and consequences: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 762–773. https://doi.org/10.1177/0004867412450471
   PubMed Web of Science ®Google Scholar
• Weir, K. (2012, June). The roots of mental illness. Monitor on Psychology. https://www.apa.org/monitor/2012/06/roots
   Google Scholar
• WHO. (2015). WHO global strategy on integrated people-centred health services 2016–2026. http://www.who.int/servicedeliverysafety/areas/people-centred-care/en.
   Google Scholar
• Zisman-Ilani, Y., Shern, D., Deegan, P., Kreyenbuhl, J., Dixon, L., Drake, R., Torrey, W., Mishra, M., Gorbenko, K., & Elwyn, G. (2018). Continue, adjust, or stop antipsychotic medication: Developing and user testing an encounter decision aid for people with first-episode and long-term psychosis. BMC Psychiatry, 18(1). https://doi.org/10.1186/s12888-018-1707-x
   PubMedGoogle Scholar